Steve Hibbert

2.1k citations
8 papers · 1.2k · 2 hit papers · h-index 8

Impact in

Papers in

    • Parkinson's Disease Mechanisms and Treatments 6
    • Inflammatory Bowel Disease 2

Steve Hibbert

8 papers receiving 1.2k citations

Steve Hibbert's Hit Papers

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial 2025 · 94 citations
940+3+6Years since publication200400600

Peers

Steve Hibbert
Comparison fields: 5 of 59
  • Neurology 604
  • Neurology 87
  • Endocrinology, Diabetes and Metabolism 175
  • Genetics 212
  • Aging 11
Replace Brice Laurens with:
Brice Laurens France
Luca Zampedri United Kingdom
Olivier Colin France
Natalia Budnik United Kingdom
Maria A. Costa-Besada Spain
Petros Takousis United Kingdom
Carola Rotermund Germany
Peng Feng China
Jiunn-Tay Lee Taiwan
M Konagaya Japan
Steve Hibbert relative to Brice Laurens France Brice Laurens's profile →
Citations per field
00.5×5×11.8×
Brice Laurens · 1×
Citations per year

Countries citing papers authored by Steve Hibbert

Since Specialization
Citations

This map shows the geographic impact of Steve Hibbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Hibbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Hibbert more than expected).

Fields of papers citing papers by Steve Hibbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Hibbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Hibbert. The network helps show where Steve Hibbert may publish in the future.

Co-authors

The 17 scholars most cited alongside Steve Hibbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Hibbert Line = papers co-authored together Steve Hibbert links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2017723
2 2018202
3
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Hit paper breakdown →
202594
4 201867
5 201865
6 202164
7 202218
8 201810

About Steve Hibbert

Steve Hibbert is a scholar working on Neurology, Genetics, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (6 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Neurology (604 citations), Neurology (87 citations), Endocrinology, Diabetes and Metabolism (175 citations), Genetics (212 citations) and Aging (11 citations). Steve Hibbert has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Natalia Budnik, Patricia Dowsey Limousin, Thomas Foltynie, Icíar Avilés-Olmos, Kashfia Chowdhury, Dilan Athauda, Luca Zampedri, Kate Maclagan, Simon S. Skene and Nigel H. Greig. Their work appears in journals such as The Lancet, Journal of Parkinson s Disease, Journal of Crohn s and Colitis, BMJ Open and ˜The œLancet. Gastroenterology & hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact